Accounting & Tax
Credit & Capital
Risk & Compliance
Strong Investor Demand Leads Alibaba to Hike IPO Price
Set to debut Sept. 19 on the New York Stock Exchange under the ticker symbol "BABA," Alibaba's IPO is poised to be the largest ever.
Cognizant Buys Health-care IT Provider
To shore up its declining health-care business, Cognizant scores its biggest deal yet.
Bitcoin Breaks New Ground With First Regulator-Approved Swap
A new derivative product from TeraExchange will allow clients to hedge against drastic price swings.
Junk Bond Exodus Resumes After August Rally
Speculative-grade issuers have to give a little more to get investors to buy new bond offerings.
Twitter CFO Gives Wall Street Something to Tweet About
The social media giant plans to tap the bond markets with a convertible debt offering, just two months after former banker Anthony Noto became CFO.
Treasury Keeps Up Rhetoric on Tax Inversions
Treasury Secretary Jack Lew says he is close to a decision on how to prevent firms from "effectively renouncing their citizenship."
Detroit’s Biggest Liability: Obsolete IT Systems
The bankrupt city's CFO and CIO testify that Detroit's information systems infrastructure is "fundamentally broken."
Credit Markets Need An Alternative to Libor — Fast
Federal Reserve Governor Powell says a "horrible mess" could ensue if a substitute to the London Interbank Offered Rate isn't found.
Activists Urge SEC to Require Disclosure of Political Spending
By not forcing companies to reveal their political contributions, the Securities and Exchange Commission is caving into partisan pressure, say activists.
Jobs Growth Cooled in August
After weeks of relatively strong economic reports and employment gains, hiring by U.S. businesses slowed last month.
Only the Wealthy Gained During the Economic Recovery
A new Federal Reserve report reveals that the income disparities between the rich and the average American only increased during the economic recovery.
Hospira-Danone Tax Inversion Deal Stalls
The $5 billion cross-border deal involving the French company's medical nutrition business is apparently on hold.
Subscribe to get CFO's reporting in your inbox